Evaluation of Multiparametric Magnetic Resonance Imaging in Detection and Prediction of Prostate Cancer

PLoS ONE - Tập 10 Số 6 - Trang e0130207
Rui Wang1, He Wang1, Chenglin Zhao1, Juan Hu2, Yuanyuan Jiang1, Yanjun Tong3, Ting Liu4, Rong Huang5, Xiaoying Wang1
1Department of Radiology, Peking University First Hospital, Beijing, China
2Department of Radiology, First Affiliated Hospital of Kunming Medical University, YunNan, China
3Department of Radiology, Aerospace Central Hospital, Beijing, China
4Department of Radiology, Dongzhimen Hospital, Beijing, China.
5Department of Radiology, Peking University Shenzhen Hospital, Guangdong, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

SW Heijmink, 2011, State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer, Acta Oncol, 50, 25, 10.3109/0284186X.2010.578369

AP Kirkham, 2006, How good is MRI at detecting and characterising cancer within the prostate?, Eur Urol, 50, 1163, 10.1016/j.eururo.2006.06.025

A Heidenreich, 2014, EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013, Eur Urol, 65, 124, 10.1016/j.eururo.2013.09.046

HB Carter, 2013, Early Detection of Prostate Cancer: AUA Guideline, J Urol, 190, 419, 10.1016/j.juro.2013.04.119

CM Hoeks, 2011, Prostate cancer: multiparametric MR imaging for detection, localization, and staging, Radiology, 261, 46, 10.1148/radiol.11091822

D Portalez, 2010, Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies, Eur Radiol, 20, 2781, 10.1007/s00330-010-1868-6

A Villers, 2009, Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance, Curr Opin Urol, 19, 274, 10.1097/MOU.0b013e328329a2ed

JO Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y

L Dickinson, 2011, Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 59, 477, 10.1016/j.eururo.2010.12.009

A Heidenreich, 2011, Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use, Eur Urol, 59, 495, 10.1016/j.eururo.2011.01.013

M Abd-Alazeez, 2014, Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard, Prostate Cancer Prostatic Dis, 17, 40, 10.1038/pcan.2013.43

FH Schröder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084

J Hugosson, 2010, Mortality results from the Göteborg randomised population-based prostate-cancer screening trial, Lancet Oncol, 11, 725, 10.1016/S1470-2045(10)70146-7

A Tanimoto, 2007, Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging, J Magn Reson Imaging, 25, 146, 10.1002/jmri.20793

Y Komai, 2013, High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy, J Urol, 190, 867, 10.1016/j.juro.2013.03.078

JE Thompson, 2014, Multiparametric Magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study, J Urol, 192, 67, 10.1016/j.juro.2014.01.014

D Junker, 2013, Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer, Biomed Res Int, 2013, 252939, 10.1155/2013/252939

Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. Eur Urol 2014 (in press).

AB Rosenkrantz, 2013, Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales, Radiology, 269, 482, 10.1148/radiol.13122233

DD Orsted, 2012, Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population, Eur Urol, 61, 865, 10.1016/j.eururo.2011.11.007

G Lucarelli, 2012, Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml, Prostate, 72, 1611, 10.1002/pros.22514

K Miller, 2007, The continuing role of PSA in the detection and management of prostate cancer, Eur Urol Suppl, 6, 327, 10.1016/j.eursup.2006.12.001

S Rais-Bahrami, 2013, Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer, J Urol, 190, 1721, 10.1016/j.juro.2013.05.052

HA Vargas, 2012, Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer, J Urol, 188, 1732, 10.1016/j.juro.2012.07.024

V Fradet, 2010, Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging, Radiology, 256, 176, 10.1148/radiol.10091147

American College of Radiology. MR Prostate Imaging Reporting and Data System version 2.0. Accessed Month YYYY. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.acr.org/Quality-Safety/Resources/PIRADS/" xlink:type="simple">http://www.acr.org/Quality-Safety/Resources/PIRADS/</ext-link>.